Published :
Tables : 45
Figures : 44
Category : Healthcare
No. of Pages : 215
Report Code : HC-1266
Medical Aesthetics Market is estimated to value at a CAGR of over 10% during the forecast period 2022 to 2028. Medical aesthetic devices are used for treating a person’s impairments related to aesthetic appearances like unwanted hair, cellulite, scars, spider veins, excessive fat, skin discoloration, moles, skin laxity, wrinkles and liver spots. Aesthetic medicines include both non-surgical and surgical procedures and physicians may choose a combination of both to intensify the patient’s physical appearance. Convenient replacement of missing or dysfunctional body parts caused by trauma, accidents and other congenital disorders is possible by the usage of medical aesthetic implants. Technological advancements, increase in demand for non-invasive or minimally invasive reconstruction surgical operations, increase in trauma cases and road accidents, high incidence of breast cancer, rise in number of cosmetology surgeons, high prevalence of congenital face and tooth deformities and increase in the number of awareness programs like breast reconstructive awareness campaign, which was initiated in the United States, steer the medical aesthetic devices market growth. Although, low reimbursements, high treatment costs, and risk of implant-associated malfunctions are primary factors that restrain this market growth. Rise in popularity of celebrities amongst the young population who encourage them to look aesthetically appealing, increase in preference for a better quality of life, growing medical tourism and are expected to provide numerous lucrative opportunities for market players which shall expand the medical aesthetics market size. Key players included in the global medical aesthetics market industry are Allergan, Alma Lasers Ltd., Anika Therapeutics Inc., Cutera Inc., Cynosure, El.En S.P.A, Fotona D.O.O, Galderma, Johnson & Johnson, Merz Aesthetics Inc., Medytox Inc., Sientra Inc., Sinclair Pharma PLC, Solta Medical, Syneron Medical Ltd. Medical Aesthetics Market Segmentation: By Product • Facial Aesthetic Products o Botulinum Toxin o Dermal Filters • Natural Dermal Filters • Synthetic Dermal Filters o Chemical Peels o Microdermabrasion Devices • Body Contouring Devices o Non-Surgical Fat Reduction Devices o Cellulite Reduction Devices o Liposuction Devices • Cosmetic Implants o Breast Implants Silicone Breast Implants Saline Breast Implants o Facial Implants o Other Cosmetic Implants • Physician-Dispensed Cosmeceuticals and Skin Lighteners • Skin Aesthetic Devices o Laser Skin Resurfacing Devices o Non-Surgical Skin Tightening Devices o Micro-Needling Products o Light Therapy Devices • Physician-Dispensed Eyelash Products • Hair Removal Devices o Laser Hair Removal Devices o IPL Hair Removal Devices • Tattoo Removal Devices • Thread Lift Products • Nail Treatment Laser Devices By End User Clinics, Hospitals and Medical S.P.A. Beauty Centres Home Care Settings By Region North America Europe Asia Pacific Latin America Middle East & Africa FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global medical aesthetics market by product, by end user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Medical aesthetic devices are used for treating a person’s impairments related to aesthetic appearances like unwanted hair, cellulite, scars, spider veins, excessive fat, skin discoloration, moles, skin laxity, wrinkles and liver spots. Aesthetic medicines include both non-surgical and surgical procedures and physicians may choose a combination of both to intensify the patient’s physical appearance. Convenient replacement of missing or dysfunctional body parts caused by trauma, accidents and other congenital disorders is possible by the usage of medical aesthetic implants.
Technological advancements, increase in demand for non-invasive or minimally invasive reconstruction surgical operations, increase in trauma cases and road accidents, high incidence of breast cancer, rise in number of cosmetology surgeons, high prevalence of congenital face and tooth deformities and increase in the number of awareness programs like breast reconstructive awareness campaign, which was initiated in the United States, steer the medical aesthetic devices market growth. Although, low reimbursements, high treatment costs, and risk of implant-associated malfunctions are primary factors that restrain this market growth. Rise in popularity of celebrities amongst the young population who encourage them to look aesthetically appealing, increase in preference for a better quality of life, growing medical tourism and are expected to provide numerous lucrative opportunities for market players which shall expand the medical aesthetics market size.
Key players included in the global medical aesthetics market industry are Allergan, Alma Lasers Ltd., Anika Therapeutics Inc., Cutera Inc., Cynosure, El.En S.P.A, Fotona D.O.O, Galderma, Johnson & Johnson, Merz Aesthetics Inc., Medytox Inc., Sientra Inc., Sinclair Pharma PLC, Solta Medical, Syneron Medical Ltd.
Medical Aesthetics Market Segmentation:
By Product
• Facial Aesthetic Products o Botulinum Toxin o Dermal Filters • Natural Dermal Filters • Synthetic Dermal Filters o Chemical Peels o Microdermabrasion Devices • Body Contouring Devices o Non-Surgical Fat Reduction Devices o Cellulite Reduction Devices o Liposuction Devices • Cosmetic Implants o Breast Implants Silicone Breast Implants Saline Breast Implants o Facial Implants o Other Cosmetic Implants • Physician-Dispensed Cosmeceuticals and Skin Lighteners • Skin Aesthetic Devices o Laser Skin Resurfacing Devices o Non-Surgical Skin Tightening Devices o Micro-Needling Products o Light Therapy Devices • Physician-Dispensed Eyelash Products • Hair Removal Devices o Laser Hair Removal Devices o IPL Hair Removal Devices • Tattoo Removal Devices • Thread Lift Products • Nail Treatment Laser Devices
By End User
By Region
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Medical Aesthetics Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Type Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Medical Aesthetics Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Medical Aesthetics Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Type Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Type Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Medical Aesthetics Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Facial Aesthetic Products 7.1.1. Botulinum Toxin 7.1.2. Dermal Filters 7.1.2.1. Natural Dermal Filters 7.1.2.2. Synthetic Dermal Filters 7.1.3. Chemical Peels 7.1.4. Microdermabrasion Devices 7.2. Body Contouring Devices 7.2.1. Non-Surgical Fat Reduction Devices 7.2.2. Cellulite Reduction Devices 7.2.3. Liposuction Devices 7.3. Cosmetic Implants 7.3.1. Breast Implants 7.3.1.1. Silicone Breast Implants 7.3.1.2. Saline Breast Implants 7.3.2. Facial Implants 7.3.3. Other Cosmetic Implants 7.4. Physician-Dispensed Cosmeceuticals and Skin Lighteners 7.5. Skin Aesthetic Devices 7.5.1. Laser Skin Resurfacing Devices 7.5.2. Non-Surgical Skin Tightening Devices 7.5.3. Micro-Needling Products 7.5.4. Light Therapy 7.6. Physician-Dispensed Eyelash Products 7.7. Hair Removal Devices 7.7.1. Laser hair Removal Devices 7.7.2. IPL Hair Removal Devices 7.8. Tattoo Removal Devices 7.9. Thread Lift Products 7.10.Nail Treatment Laser Devices 8. Medical Aesthetics Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Clinics, Hospitals and Medical S.P.A. s 8.2. Beauty Centres 8.3. Home Care Settings 9. North America Medical Aesthetics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2022-2028 10. Latin America Medical Aesthetics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. Brazil 10.2.2. Venezuela 10.2.3. Argentina 10.2.4. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2022-2028 11. Europe Medical Aesthetics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2022-2028 12. Asia Pacific Medical Aesthetics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 13. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. GCC 13.2.2. Israel 13.2.3. South Africa 13.2.4. Rest of MEA 13.3. Market Size (USD Million) Forecast for MEA 2022-2028 14. Market Share Analysis and Competitive Landscape 14.1. Global Landscape - Key Players, Revenue and Presence 14.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 14.3. Global Emerging Companies 14.4. North America - Market Share Analysis and Key Regional Players 14.5. Europe - Market Share Analysis and Key Regional Players 14.6. Asia Pacific - Market Share Analysis and Key Regional Players 14.7. Global Key Player - Growth Matrix 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 15.1. Allergan 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Alma Lasers Ltd. 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. Anika Therapeutics Inc. 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Cutera Inc. 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5. Cynosure 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6. El.En S.P.A 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Fotona D.O.O. 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Galderma 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. Johnson & Johnson 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10.Merz Aesthetics Inc. 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11.Medytox Inc. 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 15.12.Sientra Inc. 15.12.1. Company Overview 15.12.2. Product Portfolio 15.12.3. SWOT Analysis 15.12.4. Financial Overview 15.12.5. Strategic Overview 15.13.Sinclair Pharma PLC 15.13.1. Company Overview 15.13.2. Product Portfolio 15.13.3. SWOT Analysis 15.13.4. Financial Overview 15.13.5. Strategic Overview 15.14.Solta Medical 15.14.1. Company Overview 15.14.2. Product Portfolio 15.14.3. SWOT Analysis 15.14.4. Financial Overview 15.14.5. Strategic Overview 15.15.Syneron Medical Ltd. 15.15.1. Company Overview 15.15.2. Product Portfolio 15.15.3. SWOT Analysis 15.15.4. Financial Overview 15.15.5. Strategic Overview 16. Pre and Post COVID-19 Impact 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Medical Aesthetics Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Type Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Medical Aesthetics Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Medical Aesthetics Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Type Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Type Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Medical Aesthetics Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Facial Aesthetic Products 7.1.1. Botulinum Toxin 7.1.2. Dermal Filters 7.1.2.1. Natural Dermal Filters 7.1.2.2. Synthetic Dermal Filters 7.1.3. Chemical Peels 7.1.4. Microdermabrasion Devices 7.2. Body Contouring Devices 7.2.1. Non-Surgical Fat Reduction Devices 7.2.2. Cellulite Reduction Devices 7.2.3. Liposuction Devices 7.3. Cosmetic Implants 7.3.1. Breast Implants 7.3.1.1. Silicone Breast Implants 7.3.1.2. Saline Breast Implants 7.3.2. Facial Implants 7.3.3. Other Cosmetic Implants 7.4. Physician-Dispensed Cosmeceuticals and Skin Lighteners 7.5. Skin Aesthetic Devices 7.5.1. Laser Skin Resurfacing Devices 7.5.2. Non-Surgical Skin Tightening Devices 7.5.3. Micro-Needling Products 7.5.4. Light Therapy 7.6. Physician-Dispensed Eyelash Products 7.7. Hair Removal Devices 7.7.1. Laser hair Removal Devices 7.7.2. IPL Hair Removal Devices 7.8. Tattoo Removal Devices 7.9. Thread Lift Products 7.10.Nail Treatment Laser Devices
8. Medical Aesthetics Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Clinics, Hospitals and Medical S.P.A. s 8.2. Beauty Centres 8.3. Home Care Settings
9. North America Medical Aesthetics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2022-2028
10. Latin America Medical Aesthetics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. Brazil 10.2.2. Venezuela 10.2.3. Argentina 10.2.4. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2022-2028
11. Europe Medical Aesthetics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2022-2028
12. Asia Pacific Medical Aesthetics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
13. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. GCC 13.2.2. Israel 13.2.3. South Africa 13.2.4. Rest of MEA 13.3. Market Size (USD Million) Forecast for MEA 2022-2028
14. Market Share Analysis and Competitive Landscape 14.1. Global Landscape - Key Players, Revenue and Presence 14.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 14.3. Global Emerging Companies 14.4. North America - Market Share Analysis and Key Regional Players 14.5. Europe - Market Share Analysis and Key Regional Players 14.6. Asia Pacific - Market Share Analysis and Key Regional Players 14.7. Global Key Player - Growth Matrix
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 15.1. Allergan 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Alma Lasers Ltd. 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. Anika Therapeutics Inc. 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Cutera Inc. 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5. Cynosure 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6. El.En S.P.A 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Fotona D.O.O. 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Galderma 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. Johnson & Johnson 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10.Merz Aesthetics Inc. 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11.Medytox Inc. 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 15.12.Sientra Inc. 15.12.1. Company Overview 15.12.2. Product Portfolio 15.12.3. SWOT Analysis 15.12.4. Financial Overview 15.12.5. Strategic Overview 15.13.Sinclair Pharma PLC 15.13.1. Company Overview 15.13.2. Product Portfolio 15.13.3. SWOT Analysis 15.13.4. Financial Overview 15.13.5. Strategic Overview 15.14.Solta Medical 15.14.1. Company Overview 15.14.2. Product Portfolio 15.14.3. SWOT Analysis 15.14.4. Financial Overview 15.14.5. Strategic Overview 15.15.Syneron Medical Ltd. 15.15.1. Company Overview 15.15.2. Product Portfolio 15.15.3. SWOT Analysis 15.15.4. Financial Overview 15.15.5. Strategic Overview
16. Pre and Post COVID-19 Impact 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations
17. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics